June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Dry eye severity and Quality of Life in Primary and Secondary Sjögren s Syndrome with standard tests and tear biomarkers.
Author Affiliations & Notes
  • Fernando Morales-Wong
    Departamento de Oftalmología , Hospital Universitario "Dr. José Eleuterio González" , Monterrey, Nuevo León, Mexico
  • Karim Mohamed-Noriega
    Departamento de Oftalmología , Hospital Universitario "Dr. José Eleuterio González" , Monterrey, Nuevo León, Mexico
  • Jibran Mohamed-Noriega
    Departamento de Oftalmología , Hospital Universitario "Dr. José Eleuterio González" , Monterrey, Nuevo León, Mexico
  • Gerardo Villarreal Méndez
    Departamento de Oftalmología , Hospital Universitario "Dr. José Eleuterio González" , Monterrey, Nuevo León, Mexico
  • Jesus Mohamed
    Departamento de Oftalmología , Hospital Universitario "Dr. José Eleuterio González" , Monterrey, Nuevo León, Mexico
  • Janett Riega-Torres
    Departamento de Reumatología, Hospital Universitario "Dr. José Eleuterio González", UANL, Monterrey, Mexico
  • Mario Alberto Garza-Elizondo
    Departamento de Reumatología, Hospital Universitario "Dr. José Eleuterio González", UANL, Monterrey, Mexico
  • Footnotes
    Commercial Relationships   Fernando Morales-Wong, None; Karim Mohamed-Noriega, None; Jibran Mohamed-Noriega, None; Gerardo Villarreal Méndez, None; Jesus Mohamed, None; Janett Riega-Torres, None; Mario Garza-Elizondo, None
  • Footnotes
    Support  PAICYT 2015 SA161-15
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 2674. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Fernando Morales-Wong, Karim Mohamed-Noriega, Jibran Mohamed-Noriega, Gerardo Villarreal Méndez, Jesus Mohamed, Janett Riega-Torres, Mario Alberto Garza-Elizondo; Dry eye severity and Quality of Life in Primary and Secondary Sjögren s Syndrome with standard tests and tear biomarkers.. Invest. Ophthalmol. Vis. Sci. 2017;58(8):2674.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To compare dry eye severity with conventional tests, biomarkers and quality of life (QoL) tests between patients with primary and secondary Sjögren’s syndrome (1SS y 2SS).

Methods : This is a prospective, consecutive, and transversal case series of patients with 1SS and 2SS confirmed with salivary gland biopsy, serology and/or SICCA Ocular Staining Score (SICCA OSS) according to 2012 classification criteria.
The ophthalmic and dry eye evaluations were Schirmer’s test without anesthesia, tear break-up time (TBUT), tear osmolarity (Osm), esthesiometry, three Ocular Surface Staining (OSS) (Oxford, NEI-CLEK and SICCA OSS), Matrix metalloproteinase 9 (MMP9) and the Ocular Surface Disease Index (OSDI). Statistical analysis was performed with T test and Chi Square test accordingly.

Results : We evaluated 141 eyes of 71 patients with 1SS and 48 eyes of 24 patients with 2SS, Mean age ± standard deviation (SD) was 52.62 ± 12.90 and 55.58 ± 9.83 years respectively. Mean ± SD in 1SS and 2SS were as follow: TBUT 4.53 ± 2.16 vs 5.73 ± 4.16, Schirmer’s test 9.93 ± 9.6 vs 13.81 ±11.26, esthesiometry 5.65 ± 1.0 vs 5.53 ± 1.3, Osm 319.58 ±24.70 vs 311.78 ± 24.63, SICCA OSS 7.233 ± 3.46 vs 6.19 ± 3.40, Oxford 5.28 ± 3.28 vs 4.16 ± 3.17, NEI-CLEK 5.50 ± 3.95 vs 4.00 ± 4.12, OSDI 44.69 ± 24.59 vs 44.24 ± 22.73, DEQ5 11.63 ± 4.84 vs 11.09 ± 5.24, VFQ25 73.88 ±20.23 vs 72.87 ± 20.89. MMP9 were positive in 37 (26.42%) and 11(22.91%) eyes in primary SS and secondary SS respectably.
The following tests were significantly more severe in 1SS: TBUT (p=0.01), Schirmer's test (p 0.02), Oxford (p=0.04 ) and NEI-CLEK (p=0.02). the other tests, including Osm, MMP9, SICCA OSS and the QoL tests were not significantly different between 1SS and 2SS.

Conclusions : Mean Osm showed a non-significant tendency to be higher in 1SS
The percentage of eyes with positive MMP9 was similar in 1SS and 2SS. Qol tests were similar between both groups. Only the standard tests of TBUT and Schirmer were significantly higher in 1SS. The OSS Oxford and NEI CLEK were significantly higher in 1SS, whereas OSS SICCA was not significantly different between groups.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×